Background: Treating HFpEF (heart failure with preserved ejection fraction) is complex due to its diverse origins, leaving many patients with limited options. While diuretics offer symptom relief, most therapies don’t markedly improve outcomes. SGLT2 inhibitors, particularly Dapagliflozin, show potential in reducing cardiovascular events. Yet, guidelines for HFpEF and HFmrEF are vague regarding SGLT2 use. This [...]

Background: The diagnosis of sepsis is often associated with high rates of morbidity and mortality. When it occurs in patients with Heart failure (HF), those rates increase dramatically. This study focuses on the differences in the outcomes in septic patients with Heart Failure with preserved Ejection Fraction (HFpEF) versus patients with Heart Failure with reduced [...]